Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

InterCure Ltd. INCR NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
$85.67
+11172.4%

InterCure Ltd. (INCR) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.

Analyst Consensus — INCR

Buy
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts
Price Targets

No price target data available.

People Also View

RGC
RGC
Regencell Bioscience Holdings Limited
$30.11
-6.61%
 PBH
PBH
Prestige Consumer Healthcare Inc.
$56.66
-0.32%
 PAHC
PAHC
Phibro Animal Health Corporation
$59.02
-0.94%
 COLL
COLL
Collegium Pharmaceutical, Inc.
$35.64
+0.06%
 PCRX
PCRX
Pacira BioSciences, Inc.
$23.75
-1.29%
 VRNOF
VRNOF
Verano Holdings Corp.
$1.30
+8.33%
 SSIC
SSIC
Silver Spike Investment Corp.
$10.74
+1.27%
 VEXTF
VEXTF
Vext Science, Inc.
$0.21
+5.08%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message